Genentech Inc. is recalling Susvimo (ranibizumab injection) 100mg/mL and its ocular implant delivery system because the commercial implants do not meet manufacturing specifications. This recall affects 452 vials and implants. A few patients have already reported issues with the implants that render them non-functioning, meaning the medication cannot be delivered as intended. If you are a healthcare provider using these systems, you should stop using the recalled lots immediately and return them to the manufacturer.
The ocular implants are defective and may fail to function correctly. This prevents the medication from being properly administered to the patient's eye. Several reports indicate patients have experienced non-functioning implants in clinical use.
Sold as a carton containing one single-dose vial and one initial fill needle.
Sold as a carton labeled as Susvimo Ocular Implant with Insertion Tool Assembly.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.